Individualized low-dose growth hormone (GH) treatment in GH-deficient adults with childhood-onset disease: Metabolic effects during fasting and hypoglycemia

Metabolism: Clinical and Experimental

Volumn 48, Issue 8, 1999, Pages 1003-1010

  Bülow, Birgitta ^a   Agardh, Carl David ^a   Eckert, Bodil ^a   Erfurth, Eva Marie ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CORTISONE ACETATE; GLUCOSE; GROWTH HORMONE; INSULIN; LEVOTHYROXINE SODIUM; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; VASOPRESSIN;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CRANIOPHARYNGIOMA; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOGONADISM; HYPOPITUITARISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROLACTINOMA; TREATMENT OUTCOME;

EID: 0032838046     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90197-X     Document Type: Article

References (50)

1. Johnston DG, Davies RR, Prescott RWG: Regulation of growth hormone secretion in man: A review. J R Soc Med 78:319-327, 1985
2. Ho KY, Veldhuis JD, Johnson ML, et al: Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968-975, 1988
3. Wolfsdorf JI, Sadeghi-Nejad A, Senior B: Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism 32:457-462, 1983
4. Bougneres P-F, Artavia-Loria E, Ferre P, et al: Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 61:1152-1157, 1985
5. Haymond MW. Karl I, Weldon VV, et al: The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 42:846-856, 1976
6. Hopwood NJ, Forsman PJ, Kenny FM, et al: Hypoglycemia in hypopituitary children. Am J Dis Child 129:918-926, 1975
7. Attanasio AF, Lamberts SWJ, Matranga AMC, et al: Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88, 1997
8. Salomon F, Cuneo RC, Umpleby AM, et al: Glucose and fat metabolism in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 41:315-322, 1994
9. Fowelin J, Attvall S, Lager I, et al: Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency Metabolism 42:1443-1447, 1993
10. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
11. Binnerts A, Swart GR, Wilson JHP, et al: The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocnnol (Oxf) 37:79-87, 1992
12. Degerblad M, Elgindy N, Hall K, et al: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 126:387-393, 1992
13. Randle PJ, Garland PB, Hales CN: The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
14. O'Neal DN, Kalfas A, Dunning PL, et al: The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: A minimal model analysis. J Clin Endocrinol Metab 79:975-983, 1994
15. Moller N, Pörksen N, Ovesen P, et al: Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans. Horm Metab Res 25:175-179, 1993
16. Merimee TJ, Felig P, Marliss E, et al: Glucose and lipid homeostasis in the absence of human growth hormone. J Clin Invest 50:574-582, 1971
17. Cryer PE: Glucose counterregulation in man. Diabetes 30:261-264, 1981
18. Yeoh SI, Baxter RC: Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol (Copenh) 119:465-473, 1988
19. Baxter RC: Insulin-like growth factor (IGF) binding proteins: The role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand Suppl 372:107-114, 1991
20. Lee PDK, Conover CA, Powell DR: Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4-29, 1993
21. Bratusch-Marrain PR, Smith D, DeFronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982, 1982
22. Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation: The relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism 29:1164-1175, 1980 (suppl 1)
23. Diamond MP, Simonson DC, DeFronzo RA: Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 52:204-208, 1989
24. Haffner SM, Karhapää P, Mykkänen L, et al: Insulin resistance, body fat distribution and sex hormones in men. Diabetes 43:212-219, 1994
25. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
26. Thorell JI, Larson SM: Radioimmunoassay and Related Techniques. St Louis, MO, Mosby, 1978, pp 205-211
27. Eriksson BM, Persson BA: Determination of catecholamines in rat heart tissue and plasma by liquid chromatography with electrochemical detection. J Chromatogr 228:143-154, 1982
28. von Schenk H, Nilsson OR: Radioimmunoassay of extracted glucagon compared with three non-extraction assays. Clin Chim Acta 109:183-191, 1981
29. Póvoa G, Roovete A, Hall K: Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107:563-570, 1984
30. Ashworth L, Gibb I, Alberti KGMM: HemoCue: Evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 38:1479-1482, 1992
31. Pemello G, De Feo P, Torlone E, et al: Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes melhtus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33:52-59, 1990
32. Al-Shoumer KAS, Ali K. Anyaoku V, et al: Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clin Endocrinol (Oxf) 45:171-178, 1996
33. Chipman JJ, Attanasio AF, Birkett MA, et al: The safety profile of GH replacement therapy in adults. Clin Endocrinol (Oxf) 46:473-481, 1997
34. Weaver JU, Monson JP, Noonan K, et al: The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153-159, 1995
35. Whitehead HM, Boreham C, McIlrath EM, et al: Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled crossover study Clin Endocrinol (Oxf) 36:45-52, 1992
36. Snyder PJ, Lawrence DA: Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51:1335-1339, 1980
37. Johannsson G, Rosén T, Bengtsson B-Å: Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults Clin Endocrinol (Oxf) 47:571-581, 1997
38. Bengtsson B-Å, Edén S, Lönn L, et al: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317, 1993
39. De Boer H, Blok G-J, Voerman B, et al: The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab 80:2069-2076, 1995
40. Raben MS, Hollenberg CH: Effect of growth hormone on plasma fatty acids. J Clin Invest 39:484-488, 1959
41. Boden G. Chen X, Ruiz J, et al: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
42. Kollind M, Adamson U, Lins P-E, et al: Importance of growth hormone for blood glucose regulation following insulin-induced nocturnal hypoglycemia in insulin-dependent diabetes mellitus. Acta Med Scand 223:159-164, 1988
43. Fowelin J, Attvall S, von Schenck H, et al: Combined effect of growth hormone and cortisol on late posthypoglycemic insulin resistance in humans. Diabetes 38:1357-1364, 1989
44. Jörgensen JOL, Möller J, Alberti KGMM, et al: Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: Studies in GH-deficient patients and healthy untreated subjects. J Clin Endocnnol Metab 77:1589-1596, 1993
45. Bülow B, Erfurth EM: A low individualized GH dose to young patients with childhood onset GH deficiency normalized the serum IGF-I level without significant deterioration of glucose tolerance. Clin Endocrinol (Oxf) 50:45-55, 1999
46. Voorhess ML, MacGillivray MH: Low plasma norepinephrine responses to acute hypoglycemia in children with isolated growth hormone deficiency. J Clin Endocrinol Metab 59:790-793, 1984
47. Shamoon H, Hendler R, Sherwin RS: Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab 52:1235-1241, 1981
48. Suikkari A-M, Koivisto VA, Rutanen E-M, et al: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272, 1988
49. Holly JMP, Biddlecombe RA, Dunger DB, et al: Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) 29:667-675, 1988
50. Cotterill AM, Holly JMP, Amiel S, et al: Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia. Clin Endocrinol (Oxf) 38:633-639, 1993